New patent expiration for United Therap drug ORENITRAM
Drug Patent Watch
JULY 13, 2024
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA. It is available from one supplier.
Drug Patent Watch
JULY 13, 2024
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA. It is available from one supplier.
Drugs.com
JULY 13, 2024
SATURDAY, July 13, 2024 -- The human body is no match for extreme heat, and scorching temperatures seem to be the rule rather than the exception these days."It's hard to think of an organ that is not affected by the heat," said Craig Crandall.
Drug Patent Watch
JULY 13, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Drug Patent Watch
JULY 13, 2024
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Let's personalize your content